Table 2.
Crohn’s disease and human immunodeficiency virus treatment (in August)
Inpatient treatment | |||||
Crohn’s disease exacerbation treatment | HIV treatment | ||||
Prednisolone | 30 mg × 1 | 5 mg/wk | Emtricitabine/tenofovir disoproxil | 200 mg/245 mg × 1 | |
Metronidazole | 500 mg × 3 | Dolutegravir | 50 mg × 1 | ||
Mesalazine | 2000 mg × 2 | ||||
Azathioprine | 50 mg × 2 | ||||
Outpatient treatment | |||||
Crohn’s disease treatment | HIV treatment | ||||
Prednisolone | Eventually discontinued | Emtricitabine/tenofovir disoproxil | 200 mg/245 mg × 1 | ||
Mesalazine | 2000 mg × 2 | Dolutegravir | 50 mg × 1 | ||
Azathioprine | 50 mg × 2 |
HIV: Human immunodeficiency virus.